159 related articles for article (PubMed ID: 15003184)
1. Treatment of refractory autoimmune diseases with ablative immunotherapy.
Cohen Y; Nagler A
Autoimmun Rev; 2004 Feb; 3(2):21-9. PubMed ID: 15003184
[TBL] [Abstract][Full Text] [Related]
2. Treatment of refractory autoimmune diseases with ablative immunotherapy using monoclonal antibodies and/or high dose chemotherapy with hematopoietic stem cell support.
Cohen Y; Polliack A; Nagler A
Curr Pharm Des; 2003; 9(3):279-88. PubMed ID: 12570832
[TBL] [Abstract][Full Text] [Related]
3. Stem cell transplantation for severe autoimmune diseases: progress and problems.
Marmont AM
Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258
[TBL] [Abstract][Full Text] [Related]
4. Stem cell transplantation for autoimmune diseases.
Gratwohl A; Passweg J; Gerber I; Tyndall A;
Best Pract Res Clin Haematol; 2001 Dec; 14(4):755-76. PubMed ID: 11924920
[TBL] [Abstract][Full Text] [Related]
5. Update on monoclonal antibody therapy in chronic lymphocytic leukemia.
Zent CS; Kay NE
Clin Adv Hematol Oncol; 2004 Feb; 2(2):107-13. PubMed ID: 16163170
[TBL] [Abstract][Full Text] [Related]
6. Prevention of graft vs. host disease with alemtuzumab 'in the bag' decreases early toxicity of stem cell transplantation and in multiple myeloma is associated with improved long-term outcome.
Novitzky N; Thomas V; du Toit C
Cytotherapy; 2008; 10(1):45-53. PubMed ID: 18202974
[TBL] [Abstract][Full Text] [Related]
7. Stem cell transplantation for autoimmune diseases.
Burt RK; Verda L; Statkute L; Quigley K; Yaung K; Brush M; Oyama Y
Clin Adv Hematol Oncol; 2004 May; 2(5):313-9. PubMed ID: 16163198
[TBL] [Abstract][Full Text] [Related]
8. Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia.
Alinari L; Lapalombella R; Andritsos L; Baiocchi RA; Lin TS; Byrd JC
Oncogene; 2007 May; 26(25):3644-53. PubMed ID: 17530018
[TBL] [Abstract][Full Text] [Related]
9. Immunological reconstitution after autologous stem cell transplantation in patients with refractory systemic autoimmune diseases.
Szodoray P; Varoczy L; Papp G; Barath S; Nakken B; Szegedi G; Zeher M
Scand J Rheumatol; 2012 Mar; 41(2):110-5. PubMed ID: 21936606
[TBL] [Abstract][Full Text] [Related]
10. [Autologous and allogeneic stem cell transplantation for severe autoimmune diseases].
Oyama Y
Nihon Rinsho; 2003 Sep; 61(9):1643-54. PubMed ID: 14515736
[TBL] [Abstract][Full Text] [Related]
11. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
Robak T
Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
[TBL] [Abstract][Full Text] [Related]
12. Autologous hematopoietic stem cell transplantation for autoimmune diseases.
Tyndall A; Daikeler T
Acta Haematol; 2005; 114(4):239-47. PubMed ID: 16269864
[TBL] [Abstract][Full Text] [Related]
13. Autologous hematopoietic stem cell transplantation for severe autoimmune disease with special reference to rheumatoid arthritis.
Tyndall A;
J Rheumatol Suppl; 2001 Oct; 64():5-7. PubMed ID: 11642506
[TBL] [Abstract][Full Text] [Related]
14. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
[TBL] [Abstract][Full Text] [Related]
15. [Hematopoietic stem cell transplantation in autoimmune diseases in rheumatology practice].
Kozák T; Becvár R; Havrdová E; Pitha J; Gregora E; Pytlík R; Maaloufová J; Kobylka P; Vodvárková S
Cas Lek Cesk; 2000 Jun; 139(11):329-33. PubMed ID: 10953411
[TBL] [Abstract][Full Text] [Related]
16. Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients.
Knechtle SJ
Pediatr Transplant; 2004 Apr; 8(2):106-12. PubMed ID: 15049789
[TBL] [Abstract][Full Text] [Related]
17. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
[TBL] [Abstract][Full Text] [Related]
18. B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
Looney RJ
Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii13-ii17. PubMed ID: 15851522
[TBL] [Abstract][Full Text] [Related]
19. Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia.
Isaacs JD; Greer S; Sharma S; Symmons D; Smith M; Johnston J; Waldmann H; Hale G; Hazleman BL
Arthritis Rheum; 2001 Sep; 44(9):1998-2008. PubMed ID: 11592360
[TBL] [Abstract][Full Text] [Related]
20. B cell-targeted therapy in diseases other than rheumatoid arthritis.
Looney RJ
J Rheumatol Suppl; 2005 Feb; 73():25-8; discussion 29-30. PubMed ID: 15693113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
